Clinical Trials Browser

Phase 2/3 × UNKNOWN × Immune Checkpoint Inhibitors × Clear all

NCT05484024 2022-08-02

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

Phase 2/3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms